Compliance auditISO 20012:2026

ISO 20012:2026 — Biobanking: NK cells derived from pluripotent stem cells

Requirements for the banking of human natural killer (NK) cells derived from pluripotent stem cells, for research use: differentiation, culture, characterization, quality control, storage, thawing and transport.

control points
64
anchored clauses
28
Clauses covered
10

Clauses covered

General requirements (Clause 5)55.1 · 5.2 · 5.3 · 5.4 · 5.5
hPSCs and associated data (Clause 6)16
Generation of hPSC-NK cells (Clause 7)57.1 · 7.2 · 7.3 · 7.4 · 7.5
Characterization of hPSC-NK cells (Clause 8)88.1 · 8.2 · 8.3 · 8.4 · 8.5 · 8.6 · 8.7 · 8.8
Quality control (Clause 9)19
Storage (Clause 10)210.1 · 10.5
Thawing and culture (Clause 11)111
Disposal (Clause 12)112
Distribution — user information (Clause 13)113
Transport of hPSC-NK cells (Clause 14)314.1 · 14.2 · 14.3

Scale

CompliantOpportunity for improvementNon-compliantNot applicable

This template is used inside the platform: every finding becomes a corrective action tracked through to its evidence — something a printed grid cannot do.

Use this template

14-day trial, no credit card. The template opens in your workspace.

How this grid is built

Every control point is written in our own words, then tied to the standard's clause number. The normative text is never reproduced: the standard itself remains to be purchased from the body that publishes it. Grids are reviewed at every new edition of a standard.

Published by NormePulse — HEMC, management consulting firmUpdated

Related templates